Stefanie Mandl

2.2k total citations · 1 hit paper
25 papers, 1.4k citations indexed

About

Stefanie Mandl is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Stefanie Mandl has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Stefanie Mandl's work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and CAR-T cell therapy research (6 papers). Stefanie Mandl is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and CAR-T cell therapy research (6 papers). Stefanie Mandl collaborates with scholars based in United States and Germany. Stefanie Mandl's co-authors include Christopher H. Contag, Alexander D. Borowsky, J. Michael Bishop, Michael H. Bachmann, Boris H. Ruebner, Constadina Arvanitis, Qiwei Yang, Catherine M. Shachaf, Åsa Karlsson and Dean W. Felsher and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Stefanie Mandl

23 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

2004 701 citations Catherine M. Shachaf, Constadina Arvanitis et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefanie Mandl United States	14	789	442	323	234	148	25	1.4k
Birgit Schäfer Germany	21	1.5k 2.0×	537 1.2×	230 0.7×	145 0.6×	181 1.2×	33	2.1k
Raquel Blanco Spain	15	1.4k 1.7×	403 0.9×	209 0.6×	322 1.4×	113 0.8×	18	1.9k
Robert K. Bright United States	22	670 0.8×	477 1.1×	202 0.6×	497 2.1×	174 1.2×	60	1.5k
Joseph Rosenbluh United States	18	1.4k 1.8×	547 1.2×	336 1.0×	147 0.6×	136 0.9×	36	2.2k
Santosh K. Patnaik United States	25	1.5k 1.9×	321 0.7×	788 2.4×	328 1.4×	113 0.8×	43	2.1k
Kang Hu China	19	618 0.8×	536 1.2×	245 0.8×	216 0.9×	532 3.6×	27	1.3k
Purnima Dubey United States	20	556 0.7×	487 1.1×	141 0.4×	583 2.5×	166 1.1×	45	1.5k
H. Navabi United Kingdom	12	1.1k 1.4×	263 0.6×	386 1.2×	511 2.2×	79 0.5×	18	1.7k
Ann Cheung United States	11	716 0.9×	696 1.6×	172 0.5×	517 2.2×	123 0.8×	17	1.5k
Curtis Ruegg United States	17	911 1.2×	274 0.6×	308 1.0×	738 3.2×	83 0.6×	29	1.7k

Countries citing papers authored by Stefanie Mandl

Since Specialization

Citations

This map shows the geographic impact of Stefanie Mandl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Mandl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Mandl more than expected).

Fields of papers citing papers by Stefanie Mandl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Mandl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Mandl. The network helps show where Stefanie Mandl may publish in the future.

Co-authorship network of co-authors of Stefanie Mandl

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Mandl. A scholar is included among the top collaborators of Stefanie Mandl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Mandl. Stefanie Mandl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sennino, Barbara, Jyoti Mathur, Andrew Conroy, et al.. (2022). Abstract 563: Circulating tumor-specific T cells preferentially recognize patient-specific mutational neoantigens and infrequently recognize shared cancer driver mutations. Cancer Research. 82(12_Supplement). 563–563. 2 indexed citations

Sennino, Barbara, Andrew Conroy, Bhamini Purandare, et al.. (2020). Abstract 895: Coexpression of MHC class I-restricted neoTCRs and ectopic CD8 receptors in precision genome engineered CD4 T cells significantly potentiates antigen-specific effector functions. Cancer Research. 80(16_Supplement). 895–895. 1 indexed citations

Sennino, Barbara, Andrew Conroy, Bhamini Purandare, et al.. (2019). Abstract 1433: NeoTCR-P1, a novel neoepitope-specific adoptive cell therapy, consists of T cells with ‘younger’ phenotypes that rapidly proliferate and kill target cells upon recognition of cognate antigen. Cancer Research. 79(13_Supplement). 1433–1433. 2 indexed citations

Jacoby, Kyle, Robert Moot, William Lu, et al.. (2019). Abstract 4783: Highly efficient, non-viral precision genome engineering for the generation of personalized neoepitope-specific adoptive T cell therapies. Cancer Research. 79(13_Supplement). 4783–4783. 1 indexed citations

Foy, Susan P., Stefanie Mandl, Alain Delcayre, et al.. (2016). Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells. Cancer Immunology Immunotherapy. 65(5). 537–549. 26 indexed citations

Foy, Susan P., et al.. (2016). Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice. PLoS ONE. 11(2). e0150084–e0150084. 29 indexed citations

Mandl, Stefanie, et al.. (2014). Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 2(1). 34–34. 15 indexed citations

Mandl, Stefanie, et al.. (2014). Using Fitness Equipment to Harvest Human Kinetic Energy at the Dalplex. 1 indexed citations

Mandl, Stefanie, et al.. (2014). Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 2(1). 34–34. 1 indexed citations

10.

Mandl, Stefanie, et al.. (2014). PROSTVAC, PSA-targeted immunotherapy: New evidence for mechanism of action.. Journal of Clinical Oncology. 32(15_suppl). 3080–3080. 1 indexed citations

11.

Rountree, Ryan B., Stefanie Mandl, Kay Brinkmann, et al.. (2011). Exosome Targeting of Tumor Antigens Expressed by Cancer Vaccines Can Improve Antigen Immunogenicity and Therapeutic Efficacy. Cancer Research. 71(15). 5235–5244. 130 indexed citations

12.

Mandl, Stefanie, Ryan B. Rountree, Ulrike Dirmeier, et al.. (2011). Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells. Cancer Immunology Immunotherapy. 61(1). 19–29. 22 indexed citations

13.

Shachaf, Catherine M., Constadina Arvanitis, Åsa Karlsson, et al.. (2004). MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature. 431(7012). 1112–1117. 701 indexed citations breakdown →

14.

Mandl, Stefanie, C Marí, Matthias Edinger, et al.. (2004). Multi-modality Imaging Identifies Key Times for Annexin V Imaging as an Early Predictor of Therapeutic Outcome. Molecular Imaging. 3(1). 1 indexed citations

15.

Blankenberg, Francis G., Stefanie Mandl, Yuan Cao, et al.. (2004). Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor.. PubMed. 45(8). 1373–80. 43 indexed citations

16.

Rosol, Thomas J., Sarah H. Tannehill‐Gregg, Bruce E. LeRoy, Stefanie Mandl, & Christopher H. Contag. (2003). Animal models of bone metastasis. Cancer. 97(S3). 748–757. 158 indexed citations

17.

Franc, Benjamin L., Stefanie Mandl, Zurab Siprashvili, Paul A. Wender, & Christopher H. Contag. (2003). Breaching Biological Barriers: Protein Translocation Domains as Tools for Molecular Imaging and Therapy. Molecular Imaging. 2(4). 2 indexed citations

18.

Mandl, Stefanie, et al.. (2002). Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. Journal of Cellular Biochemistry. 87(S39). 239–248. 57 indexed citations

19.

McAllister, Andrés, et al.. (2000). Recombinant Yellow Fever Viruses Are Effective Therapeutic Vaccines for Treatment of Murine Experimental Solid Tumors and Pulmonary Metastases. Journal of Virology. 74(19). 9197–9205. 54 indexed citations

20.

Sitter, Thomas, et al.. (1998). High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells. Journal of the American Society of Nephrology. 9(11). 2005–2012. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact